Health

Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer

June 21, 2023, at The Yale Club, New York City  Featured speakers and Key Opinion Leaders include: Dr Christian Behrenbruch, DrColin Hayward, Kevin Richardson, Dr Brian Shuch and Dr Scott Tagawa Topics include Telix's urologic pipeline, development of novel therapeutics, imaging agents and techn...

2023-06-15 19:00 1798

Springer Nature to Join Seegene's OneSystem™ Business as Strategic Partner

* Seegene announces strategic partnership with Springer Nature to expand OneSystem™ Business * Seegene and Springer Nature to jointly launch global assay development project * Springer Nature expresses active support for Seegene's vision to promote participation across global scientific com...

2023-06-15 19:00 1755

Nippon Express Europe Exhibits at LogiPharma 2023 for First Time

TOKYO, June 15, 2023 /PRNewswire/ -- Nippon Express Europe GmbH, a group company of NIPPON EXPRESS HOLDINGS, INC., exhibited for the first time at "LogiPharma 2023" held inLyon, France, from Tuesday, April 25, to Thursday, April 27. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 ...

2023-06-15 14:00 1823

111, Inc. Announces First Quarter 2023 Unaudited Financial Results

SHANGHAI, June 15, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the first quart...

2023-06-15 13:22 3458

Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen

TSURUOKA, Japan, June 15, 2023 /PRNewswire/ -- Metagen Therapeutics (President & CEO:Taku Nakahara), a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of1.7 b...

2023-06-15 13:00 2512

GC Genome's New Study Reveals Link Between Gut Microbiome and High Blood Pressure

- A large Korean population study provides scientific evidence that altering the gut microbiome composition through dietary habit change can help prevent and manage the hypertension YONGIN, South Korea, June 14, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnostics company, a...

2023-06-15 08:32 1637

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...

2023-06-14 20:00 2012

Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays

SEOUL, South Korea, June 14, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnostics, to advance discussions on the expansion of it...

2023-06-14 19:00 2173

The Only Taiwanese Company to win the World Food Innovation Awards, TCI is Leading the Upcycling Sustainability in Biotech Industry

TAIPEI, June 14, 2023 /PRNewswire/ -- The 2023 World Food Innovation Awards recently announced the list of global winners. With its outstanding performance in innovation, TCI fromTaiwan won three major awards. Two natural health ingredients were recognized as Finalists, which included Banana Flow...

2023-06-14 17:17 2234

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix , a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2. This product is a companion diagnosti...

2023-06-14 09:00 1964

"Biotechnology Nourishes Life", CABIO explores the development of Synthetic Biology Industry

WUHAN, China, June 13, 2023 /PRNewswire/ -- On June 9, 2023, the Synthetic Biology Technology Development Summit was held in Wuhan Optics Valley. The Summit was hosted by China Biotech Fermentation Industry Association and jointly undertaken by CABIO Biotech (Wuhan) Co., Ltd., Hubei Society for ...

2023-06-13 21:00 2091

upGrad enters Pacific Region to set up the largest Institute of Medical Sciences

ATLANTA, June 13, 2023 /PRNewswire/ -- upGrad, Asia's largest integrated learning skilling and workforce development company announced the setting up of upGrad Institute of Medical Sciences (UIMS), a fully-offline campus in the Republic ofVanuatu to attract and train global talent with modern-day...

2023-06-13 19:08 2010

Wingderm® once again participated in the international top medical aesthetics event IMCAS

BEIJING, June 13, 2023 /PRNewswire/ -- From June 8 to 11, 2023, the international top medical aesthetic event IMCAS was successfully held in Bangkok, Thailand. Wingderm Electro-optics Ltd. (Wingderm®) is once again present as a sponsor and exhibitor of IMCAS. Wingderm® is showcasing a wide range ...

2023-06-13 14:30 2110

Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug

SAN FRANCISCO, June 12, 2023 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce...

2023-06-12 21:30 2158

Fresh2 Group Ltd. Regains Compliance with Nasdaq Listing Requirements

NEW YORK, June 12, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerc...

2023-06-12 21:00 3287

Breakthrough AI Research by Lunit Presented at CVPR 2023: Transforming Pathology with Computer Vision for Medical Applications

- Lunit's pioneering AI study to be unveiled at one of the premier computer vision conferences, innovating pathology with more accurate cell detection SEOUL, South Korea, June 12, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, toda...

2023-06-12 21:00 2047

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

SHANGHAI, June 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the launch of the Digital Online Education Platform for Common D...

2023-06-12 20:00 2233

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease

* HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. * These mission-aligned companies are collaborating to develop small-molecule therapies for Parkinson's patients, benefiting from their combined expertise in clinical development and disease biology. * T...

2023-06-12 19:00 2591

Jelenew Teams Up with Olympic Medalist Marion Clignet Teams for an Inspiring Charity Ride to raise funds to build a gym for a local school dedicated to children with epilepsy #empowerwomen

WILMINGTON, Del., June 12, 2023 /PRNewswire/ -- Jelenew, a leading luxury women's cycling brand, recently orchestrated a charity cyclosportive to uplift and advocate for individuals affected by epilepsy. This event took place on the third of June in the picturesque setting of Mauvezin, Gers, and ...

2023-06-12 13:16 1720

Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases

– Proceeds to support the development of Eccogene's clinical-stage metabolic pipeline including ECC5004, a small molecule GLP-1 receptor agonist for obesity and type 2 diabetes, and ECC4703, a THRβ full agonist for NASH and lipid disorders BOSTON and SHANGHAI, June 11, 2023 /PRNewswire/ -- Eccog...

2023-06-12 08:00 2337
1 ... 79808182838485 ... 273